期刊文献+

双醋瑞因配胶囊合点穴对中老年膝骨关节炎的疗效观察

Curative Effect Observation of Diacetate Combined with Acupoint Acupuncture on Knee Osteoarthritis of Middle-Aged and Elderly Patients
下载PDF
导出
摘要 目的 研究双醋瑞因胶囊配合点穴治疗在中老年膝骨关节炎中的应用。方法 对70例膝骨关节炎达标病例进行分析,随机分成对照组和治疗组,每组各35例。对照组给予常规治疗+双醋瑞因胶囊,治疗组患者在常规治疗基础上用双醋瑞因胶囊+手指点穴,疗程6周。对比两组治疗前后,观察其中医症候的疗效、骨性关节炎指数(WOMAC)。结果 两组患者经过6周的治疗,治疗组中医证候疗效和WOMAC评分均好于对照组,差异具有统计学意义(P<0.05)。结论 手指点穴配合双醋瑞因胶囊可加强对膝骨关节炎的治疗效果。 Objective To study application of diacetate combined with acupoint therapy in treatment of knee osteoarthritis of middle-aged and elderly.Methods The paper analyzed 70 cases knee osteoarthritis patients and divided them into control group and treatment group randomly,with 35 cases in each group.Control group was treated with routine therapy plus diacetate,while treatment group with diacetate plus finger acupuncture on the basis of routine therapy for 6 weeks.Traditional Chinese medicine symptoms effect,osteoarthritis index(WOMAC)was compared between two groups before and after treatment.Results After 6 weeks of treatment,curative effect of TCM symptoms and WOMAC scores in treatment group were better than control group,with statistically significant difference(P<0.05).Conclusion Finger acupoint acupuncture combined with diacetate capsule can enhance curative effect of knee osteoarthritis.
作者 覃良毅 覃良悦 吴理杨 QIN Liangyi;QIN Liangyue;WU Liyang(TCM Rheumatology Department,PLA No.923 Hospital,Nanning,Guangxi 530021)
出处 《智慧健康》 2023年第4期141-144,共4页 Smart Healthcare
关键词 膝骨关节炎 点穴 穴位按摩 双醋瑞因胶囊 Knee osteoarthritis Point tapping Acupoint massage Diacetate
  • 相关文献

参考文献6

二级参考文献33

  • 1唐福林,张奉春,郑文洁,李军,栗占国,苏茵,吴东海,马丽,周惠琼,黄烽,张江林,周乙雄,徐辉.双醋瑞因治疗膝骨关节炎的疗效与安全性多中心对照研究[J].中华风湿病学杂志,2005,9(7):421-424. 被引量:62
  • 2陈日高,胡一梅,何洪阳.膝骨性关节炎的中医治疗概况[J].现代中西医结合杂志,2006,15(7):973-976. 被引量:49
  • 3吕亚南.张涛研究员手法治疗膝关节损伤经验[J].陕西中医,2006,27(10):1259-1260. 被引量:11
  • 4PENDLETON A,ARDEN N, DOUGADOS M,et al. EULAR recommendations for the management of knee osteoarthritis :report of a task force of the Standing Committee fur International Clinical Studies Including Therapeutic Trials (ESC1SIT) [ J]. Ann Rheum Dis ,2000 ,59(12) :936 - 944.
  • 5ALTMAN RD, ALTMAN RD. The classification of osteoarthritis [ J ]. J Rheumatol, 1995,43 (Suppl) : S42 - S43.
  • 6BELLAMY N,BUCHANAN WW,GOLDSMITH CH,et al, Validation study of WOMAC :a health status instrument for measuring clinically important patient relevant outcomes to antirheumatic drug therapy in patients with osteoarthritis of the hip or knee[ J]. J Rheumatol, 1988,15 ( 12 ) : 1833 - 1840.
  • 7BLUMENFELD I,LIVNE E. The role of transforming growth factor (TGF)-beta, insulin-like growth factor (1GF)-1, and interleu- kin (IL) -1 in osteoarthritis and aging of joints[ J ]. Exp Gerontol, 1999,34(7) :821 - 829.
  • 8DOMAGALA F, MARTIN G, BOGDANOWICZ P,et al. Inhibition of interleukin-lbeta-induced activation of MEK/ERK pathway and DNA binding of NF-kappaB and AP-1 : potential mechanism for Diacerein effects in osteoarthritis [ J ]. Biorheology, 2006,43 (3 -4) :577 -587.
  • 9DE ISLA NG, STOLTZ JF. In vitro inhibition of IL-1 beta catabolic effects on cartilage: a mechanism involved on diacerein anti-OA properties[ J]. Biorheology,2008,45 ( 3 - 4 ) :433 - 438.
  • 10TAMURA T, SH1RAI T, KOSAKA N ,et al. Pharmacological studies of diaeerein in animal models of inflammation, arthritis and bone resorption [J]. Eur J Pharmacol,2002,4d-8 ( 1 ) :81 -S7.

共引文献1454

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部